Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOXODIAG: New Diagnostic Approach for Congenital Toxoplasmosis
NCT03385499Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2018
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Detection/quantification of T. gondii IgG and IgM secreting LyB by ELISPOT on cord blood mononuclear cells (MNC) of newborns suspected of congenital toxoplasmosis at 6 months. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03385499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03385499.